PROPANC BIOPHARMA (PPCB)

0.07
0.00 4.62
OTC
Prev Close 0.07
Open 0.07
Day Low/High 0.07 / 0.07
52 Wk Low/High 0.00 / 0.77
Volume 313.71K
Exchange OTC
Shares Outstanding 181.65B
Market Cap 13.44M
Div & Yield N.A. (N.A)

Propanc Biopharma Initiates European Validation Of Its Lead Patent

MELBOURNE, Australia, Oct. 4, 2018 /PRNewswire/ --  Propanc Biopharma, Inc.

Propanc Biopharma Enters Into Research Collaboration Agreement With The University Of Jaén

MELBOURNE, Australia, Sept. 19, 2018 /PRNewswire/ -- Propanc Biopharma, Inc.

Propanc Biopharma Provides Shareholder Update After Presenting At The 25th Annual NewsMakers In The Biotech Industry Conference

MELBOURNE, Australia, Sept. 12, 2018 /PRNewswire/ -- Propanc Biopharma, Inc.

Propanc Biopharma Selected To Present At The 25th Annual NewsMakers In The Biotech Industry

MELBOURNE, Australia, Aug. 9, 2018 /PRNewswire/ --  Propanc Biopharma Inc.

Propanc Biopharma Enters National Phase For Two Key Patents

Filed Major Jurisdictions Covering Proenzyme Composition and Method to Eradicate Cancer Stem Cells

Propanc Biopharma Is Readied for Revolutionary Cancer Treatment, CEO Says

With a promising treatment for solid tumor cancers coming down its pipeline, Propanc has its sights set on changing the way cancer is treated.